Open AccessBromelain inhibitory effect on colony formation: An In vitro Study on human AGS, PC3, and MCF7 cancer cells
Author(s) -
Farzane Raeisi,
Elham Raeisi,
Esfandiar Heidarian,
Daryoush Shahbazi-Gahroui,
Y. Lemoigne
Publication year - 2019
Publication title -
journal of medical signals and sensors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.337
H-Index - 21
ISSN - 2228-7477
DOI - 10.4103/jmss.jmss_42_18
Subject(s) - bromelain , clonogenic assay , in vitro , cancer cell , cell growth , ic50 , cell culture , chemistry , cell , mtt assay , microbiology and biotechnology , pharmacology , cancer , biology , biochemistry , medicine , enzyme , genetics , protease
Bromelain is dotted with anticancer properties on various cancer cell lines. Anticancer pathways of bromelain, as well related intervening signalization are under investigation. Investigating the inhibitory potential of bromelain on AGS, PC3, and MCF7 cells proliferation and colony formation. The bromelain inhibitory potential on AGS, PC3, and MCF7 cells proliferation at various bromelain concentrations was assessed by MTT; thereby, bromelain potency on colony formation impediment was evaluated using clonogenic assays at determined 50% inhibitory concentrations (IC 50 ) on four different cell densities (10, 50, 100, and 200 cells per well). Bromelain inhibits AGS, PC3, and MCF7 cells proliferation in such a dose-dependent manner. Determined IC 50 to AGS, PC3, and MCF7 cells were 65, 60 and 65μg/ml respectively. At IC 50 , bromelain significantly suppressed the AGS, PC3, and MCF7 cells colony formation at four treated densities (10, 50, 100 and 200 cells per well). Plating efficiency percentage and cell surviving fraction were decreased after bromelain treatment to AGS, PC3, and MCF7 human cancer cells as a function of initial cell density. The 50, 50 or 100, and 10 or 50 cells per well were considered to be optimum number of initial cell density for AGS, PC3, and MCF7 cells. Cell proliferative and colony formation inhibition are two pathways to in vitro bromelain anticancer effects. The current study displayed a dose-dependent inhibitory effect of bromelain, as well impeding colony formation AGS, PC3, and MCF7 human cancer cells.